Login
Home / 3320.HK : HKSE
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

China Resources Pharmaceutical Group Ltd.

HKD 4.26 -$0.25 (-5.54%)
HKSE · 15 Sep 2026 08:08 UTC
Previous Close
HKD 4.31
Day Range
HKD 4.26HKD 4.35
Year Range
HKD 4.22HKD 6.53
Market Cap
26.76B
AVG Volume
9.33M
Trailing/Forward PE
5.68/5.1
PEG ratio
0.66
Dividend Yield
5.62%
Next Earnings Date
2027-03-24
Primary Exchange
Hong Kong Stock ExchangeHK
Revenue (HKD)
050B100B150B200B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Net Income (HKD)
01B2B3B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Operating Income (HKD)
02.5B5B7.5B10B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EBITDA (HKD)
05B10B15B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash Flows (HKD)
-10B010B20B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
EPS (HKD)
00.20.40.621 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Expenses (HKD)
010B20B30BR&DSG&ACapex21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Cash & Debt (HKD)
050B100B150BCashLong Term DebtShort Term Debt21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
012321 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
0%5%10%15%20%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Return on Capital
0%1%2%3%4%21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Shares Outstanding
02B4B6B8B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Dividends (HKD)
00.050.10.150.2Jun 20Jun 21Jun 22Jun 23Jun 24Sep 24May 25Sep 25Jun 26Sep 26
Book Value Per Share (HKD)
010203021 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Total Assets (HKD)
0100B200B300B400B21 Q422 Q222 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
PE Ratio
33.544.55med 4.19Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Free Cash Flow Yield
60%80%100%120%140%med 89.19%Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Sales
0.040.050.060.070.08med 0.06Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
EV/EBITDA
2.252.52.7533.253.5med 2.91Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price/Operating Cashflow
0.60.811.21.4med 0.93Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
Price to Book
0.20.250.30.35med 0.3Dec 24Apr 25Jul 25Nov 25Feb 26Jun 26Sep 26
China Resources Pharmaceutical Group Ltd.
3320.HK
Stockpicker

Video analysis: 3320.HK

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.